Don't miss SGLT Tools - PowerPoint slide library for SGLT2 inhibitors

Ask the Experts

  1. mavericknephro
  2. Metabolic Bone Disease and SHPT
  3. Thursday, 06 August 2015
  4.  Subscribe via email
Can phosphate binders be temporarily used in AKI if it does not respond to dietary phosphate restriction alongwith cause directed treatment of AKI?
Responses (1)
Accepted Answer Pending Moderation
Hi there,

I suppose you could, but I would ask what the goal would be? The evidence that PO4 is problematic is more-so for chronic burden, and even that is in my is debatable. My thoughts on this here:

http://ukidney.com/news/entry/dream-rct-a-placebo-controlled-trial-of-hyperphosphatemia-management

I would be more considered about other aspects of the AKI than the short term, and theoretical impact of hyperphsphatemia. Furthermore, PO4 binding would not lower PO4 levels quickly and would have little role in a patient who is not eating much (i.e. those with AKI)

Dr. Jordan Weinstein
  • Page :
  • 1


There are no replies made for this post yet.
Be one of the first to reply to this post!
Guest
Submit Your Response
Upload files or images for this discussion by clicking on the upload button below. Supports gif,jpg,png,zip,rar,pdf,jpeg,doc,docx,xls,xlsx
• Insert • Remove Upload Files (Maximum File Size: 10 MB) - NB: PLEASE REMOVE ALL IDENTIFYING DATA
ukidneyisup